Evolution of the influenza A virus genome during development of oseltamivir resistance in vitro

Journal of Virology

Volumn 88, Issue 1, 2014, Pages 272-281

  Renzette, Nicholas ^a   Caffrey, Daniel R ^a   Zeldovich, Konstantin B ^a   Liu, Ping ^a   Gallagher, Glen R ^a   Aiello, Daniel ^a   Porter, Alyssa J ^a   Kurt Jones, Evelyn A ^a   Bolon, Daniel N ^a   Poh, Yu Ping ^a,c   Jensen, Jeffrey D ^b,c   Schiffer, Celia A ^a   Kowalik, Timothy F ^a   Finberg, Robert W ^a   Wang, Jennifer P ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b EPFL   (Switzerland)

^c SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; SIALIDASE;

ARTICLE; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; EVOLUTIONARY ADAPTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOME ANALYSIS; IC 50; IN VITRO STUDY; INFLUENZA VIRUS A; MICROBIAL DIVERSITY; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES DIFFERENCE; VIRAL GENETICS; VIROGENESIS; VIRUS GENOME; VIRUS RESISTANCE; VIRUS STRAIN;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOGS; DRUG RESISTANCE, VIRAL; EVOLUTION, MOLECULAR; GENOME, VIRAL; HIGH-THROUGHPUT SCREENING ASSAYS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INHIBITORY CONCENTRATION 50; MUTATION; OSELTAMIVIR; VIRAL PLAQUE ASSAY;

EID: 84890861973     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01067-13     Document Type: Article

References (29)

1. Palese P, Shaw M. 2007. Orthomyxoviridae: the viruses and their replication, p 1647-1689. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Gubareva LV, Kaiser L, Matrosovich MN, Soo-Hoo Y, Hayden FG. 2001. Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J. Infect. Dis. 183:523-531. http://dx.doi .org/10.1086/318537.
3. Lackenby A, Hungnes O, Dudman SG, Meijer A, Paget WJ, Hay AJ, Zambon MC. 2008. Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe. Euro Surveill. 13(5):8026. http://www .eurosurveillance.org/ViewArticle.aspx?ArticleId 8026.
4. Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, St George K, Epperson S, Brammer L, Klimov AI, Bresee JS, Fry AM. 2009. Infections with oseltamivir-resistant influenza A (H1N1) virus in the United States. JAMA 301:1034-1041. http://dx.doi .org/10.1001/jama.2009.294.
5. Moscona A. 2009. Global transmission of oseltamivir-resistant influenza. N. Engl. J. Med. 360:953-956. http://dx.doi.org/10.1056/NEJMp0900648.
6. Collins PJ, Haire LF, Lin YP, Liu J, Russell RJ, Walker PA, Skehel JJ, Martin SR, Hay AJ, Gamblin SJ. 2008. Crystal structures of oseltamivirresistant influenza virus neuraminidase mutants. Nature 453:1258-1261. http://dx.doi.org/10.1038/nature06956.
7. Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Hayden FG, Sugaya N, Kawaoka Y. 2004. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364:759-765. http://dx.doi.org/10.1016/S0140-6736(04)16934-1.
8. Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y, Kawaoka Y. 2005. Avian flu: isolation of drug-resistant H5N1 virus. Nature 437:1108. http://dx.doi .org/10.1038/4371108a.
9. Nielsen R. 2005. Molecular signatures of natural selection. Annu. Rev. Genet. 39:197-218. http://dx.doi.org/10.1146/annurev.genet.39.073003 .112420.
10. Barreiro LB, Laval G, Quach H, Patin E, Quintana-Murci L. 2008. Natural selection has driven population differentiation in modern humans. Nat. Genet. 40:340-345. http://dx.doi.org/10.1038/ng.78.
11. Lauring AS, Andino R. 2010. Quasispecies theory and the behavior of RNAviruses. PLoS Pathog. 6:e1001005. http://dx.doi.org/10.1371/journal .ppat.1001005.
12. Hendricks GL, Weirich KL, Viswanathan K, Li J, Shriver ZH, Ashour J, Ploegh HL, Kurt-Jones EA, Fygenson DK, Finberg RW, Comolli JC, Wang JP. 2013. Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza A virus. J. Biol. Chem. 288:8061-8073. http://dx .doi.org/10.1074/jbc.M112.437202.
13. Zhou B, Donnelly ME, Scholes DT, St George K, Hatta M, Kawaoka Y, Wentworth DE. 2009. Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and swine origin human influenza A viruses. J. Virol. 83:10309-10313. http://dx.doi.org/10.1128 /JVI.01109-09.
14. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR. 2001. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 146:2275-2289. http://dx.doi.org/10.1007/s007050170002.
15. Wright S. 1931. Evolution in Mendelian populations. Genetics 16:97-159.
16. Caffrey DR, Dana PH, Mathur V, Ocano M, Hong EJ, Wang YE, Somaroo S, Caffrey BE, Potluri S, Huang ES. 2007. PFAAT version 2.0: a tool for editing, annotating, and analyzing multiple sequence alignments. BMC Bioinformatics 8:381. http://dx.doi.org/10.1186/1471-2105 -8-381.
17. Holsinger KE, Weir BS. 2009. Genetics in geographically structured populations: defining, estimating and interpreting FST. Nat. Rev. Genet. 10: 639-650. http://dx.doi.org/10.1038/nrg2611.
18. Weir BS, Cockerham CC. 1984. Estimating F-statistics for the analysis of population structure. Evolution 38:1358-1370. http://dx.doi.org/10.2307 /2408641.
19. Holmes EC, Ghedin E, Miller N, Taylor J, Bao Y, St George K, Grenfell BT, Salzberg SL, Fraser CM, Lipman DJ, Taubenberger JK. 2005. Whole-genome analysis of human influenza A virus reveals multiple per- sistent lineages and reassortment among recent H3N2 viruses. PLoS Biol. 3:e300. http://dx.doi.org/10.1371/journal.pbio.0030300.
20. Nobusawa E, Sato K. 2006. Comparison of the mutation rates of human influenza A and B viruses. J. Virol. 80:3675-3678. http://dx.doi.org/10 .1128/JVI.80.7.3675-3678.2006.
21. Ghedin E, Holmes EC, DePasse JV, Pinilla LT, Fitch A, Hamelin ME, Papenburg J, Boivin G. 2012. Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmission. J. Infect. Dis. 206:1504-1511. http://dx.doi.org/10.1093 /infdis/jis571.
22. Ghedin E, Laplante J, DePasse J, Wentworth DE, Santos RP, Lepow ML, Porter J, Stellrecht K, Lin X, Operario D, Griesemer S, Fitch A, Halpin RA, Stockwell TB, Spiro DJ, Holmes EC, St George K. 2011. Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance. J. Infect. Dis. 203:168-174. http://dx.doi.org/10.1093/infdis/jiq040.
23. Wright S. 1932. The roles of mutation, inbreeding, crossbreeding, and selection in evolution, p 355-366. In Jones DF (ed), Proceedings of the Sixth International Congress on Genetics, vol 1. Brooklyn Botanic Garden, Menasha, WI.
24. Bloom JD, Gong LI, Baltimore D. 2010. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328: 1272-1275. http://dx.doi.org/10.1126/science.1187816.
25. Kim CU, Lew W, Williams MA, Liu H, Zhang L, Swaminathan S, Bischofberger N, Chen MS, Mendel DB, Tai CY, Laver WG, Stevens RC. 1997. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent antiinfluenza activity. J. Am. Chem. Soc. 119:681-690. http://dx.doi.org/10 .1021/ja963036t.
26. Moscona A. 2005. Oseltamivir resistance-disabling our influenza defenses. N. Engl. J. Med. 353:2633-2636. http://dx.doi.org/10.1056 /NEJMp058291.
27. Sakai A, Kaneko S, Honda M, Matsushita E, Kobayashi K. 1999. Quasispecies of hepatitis C virus in serum and in three different parts of the liver of patients with chronic hepatitis. Hepatology 30:556-561. http: //dx.doi.org/10.1002/hep.510300234.
28. Venev SV, Zeldovich KB. 2013. Segment self-repulsion is the major driving force of influenza genome packaging. Phys. Rev. Lett. 110:098104. http://dx.doi.org/10.1103/PhysRevLett.110.098104.
29. Aoki FY, Boivin G, Roberts N. 2007. Influenza virus susceptibility and resistance to oseltamivir. Antivir. Ther. 12:603- 616. http://www .intmedpress.com/journals/avt/abstract.cfm?id446&pid88.